Fe-Curcumin Nanozyme-Mediated Reactive Oxygen Species Scavenging and Anti-Inflammation for Acute Lung Injury

Abstract

Pneumonia, such as acute lung injury (ALI), has been a type of lethal disease that is generally caused by uncontrolled inflammatory response and excessive generation of reactive oxygen species (ROS). Herein, we report Fe-curcumin-based nanoparticles (Fe-Cur NPs) with nanozyme functionalities in guiding the intracellular ROS scavenging and meanwhile exhibiting anti-inflammation efficacy for curing ALI. The nanoparticles are noncytotoxic when directing these biological activities. Mechanism studies for the anti-inflammation aspects of Fe-Cur NPs were systematically carried out, in which the infected cells and tissues were alleviated through downregulating levels of several important inflammatory cytokines (such as TNF-α, IL-1β, and IL-6), decreasing the intracellular Ca 2+ release, inhibiting NLRP3 inflammasomes, and suppressing NF-κB signaling pathways. In addition, we performed both the intratracheal and intravenous injection of Fe-Cur NPs in mice experiencing ALI and, importantly, found that the accumulation of such nanozymes was enhanced in lung tissue (better than free curcumin drugs), demonstrating its promising therapeutic efficiency in two different administration methods. We showed that the inflammation reduction of Fe-Cur NPs was effective in animal experiments and that ROS scavenging was also effectively achieved in lung tissue. Finally, we revealed that Fe-Cur NPs can decrease the level of macrophage cells (CD11b lo F4/80 hi ) and CD3 + CD45 + T cells in mice, which could help suppress the inflammation cytokine storm caused by ALI. Overall, this work has developed the strategy of using Fe-Cur NPs as nanozymes to scavenge intracellular ROS and as an anti-inflammation nanodrugs to synergistically cure ALI, which may serve as a promising therapeutic agent in the clinical treatment of this deadly disease. Fe-Cur NP nanozymes were designed to attenuate ALI by clearing intracellular ROS and alleviating inflammation synergistically. Relevant cytokines, inflammasomes, and signaling pathways were studied.

Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury In Vivo and In Vitro Through the PIP2/NF-κB/NLRP3 Signaling Pathway

“…All of the mice were allocated into six groups at random according to their body weight. Intratracheal injection (i.t) was used to establish an ALI model as our previous study (21). Briefly, mice were injected with 0.4% sodium pentobarbital (i.p.)…”

Codelivery of SARS-CoV-2 Prefusion-Spike Protein with CBLB502 by a Dual-Chambered Ferritin Nanocarrier Potentiates Systemic and Mucosal Immunity

“… 18 Nanoparticles have been designed to penetrate the mucosal barrier for antigen delivery or for therapeutic application. 19 , 20 In addition, nanoparticle combinations with adjuvants have been utilized to improve protein immunogenicity. 21 The 24-unit Helicobacter pylori ( H. pylori ) ferritin spontaneously assembles nanoparticles harboring eight three-fold symmetric axes, 22 which has shown excellent potential in enhancing immune responses for trimeric antigens like influenza hemagglutinin 23 or EBV glycoprotein 350.…”

A new antioxidant made from a pterostilbene functionalized graphene nanocomposite as an efficient treatment for dry eye disease

“…There is more oxidative stress (Jiao et al, 2022), or damage from things like pollution and sunlight, in their tears. Recently, it was suggested that the increased ROS activated the inflammasome NLRP3, which caused this immune-inflammatory response (Yuan et al, 2022;Wan et al, 2022).…”